Stress-related sleep reactivity is associated with insomnia, psychopathology and suicidality in pregnant women: preliminary results

Palagini, Laura; Cipollone, Giada; Masci, Isabella; Novi, Martina; Caruso, Danila; Kalmbach, David A.; Drake, Christopher L.

doi:10.1016/j.sleep.2019.01.009

Cited by 55 publications

(59 citation statements)

References 35 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Of the 24 articles included in the analyses, all were comprised of convenience samples and none assessed insomnia symptoms using a structured clinical interview. In terms of the scales used, 12 studies used the Insomnia Severity Index (Dolatian et al., 2014; Felder et al., 2019; Fernández‐Alonso et al., 2012; Kalmbach et al., 2020; Manber et al., 2013; Mindell et al., 2015; Mourady et al., 2017; Palagini et al., 2019; Sedov, Madsen, et al., 2018; Swanson et al., 2011; Umeno et al., 2020; Wang et al., 2020), five studies used the Women`s Health Initiative Insomnia Rating Scale (Facco et al., 2010; Kızılırmak et al., 2012; Ko et al., 2012; Louis et al., 2018; Nacar & Tashan, 2019), two studies used the Insomnia Symptoms Questionnaire (Okun, Buysse, et al., 2015; Okun & O’Brien, 2018), two studies used the Athens Insomnia Scale (Román‐Gálvez et al., 2018; Wołyńczyk‐Gmaj et al., 2017), two studies used the Bergen Insomnia Scale (Dorheim et al., 2012; Osnes et al., 2020), and one study used the Basic Nordic Sleep Questionnaire (Kiviruusu et al., 2020). Table 2 displays the included studies along with the scale used to measure insomnia, cut‐scores utilized to characterize groups, and mean scores as well as associated standard deviations.…”

Section: Resultsmentioning

confidence: 99%

“…Of the 24 articles, 22 reported a mean or median maternal age, which ranged from 25.2 to 32.5 years (Dorheim et al., 2012; Facco et al., 2010; Felder et al., 2019; Fernández‐Alonso et al., 2012; Kalmbach et al., 2020; Kiviruusu et al., 2020; Kızılırmak et al., 2012; Ko et al., 2012; Louis et al., 2018; Manber et al., 2013; Mourady et al., 2017; Nacar & Tashan, 2019; Okun, Buysse, et al., 2015; Okun & O’Brien, 2018; Osnes et al., 2020; Palagini et al., 2019; Román‐Gálvez et al., 2018; Sedov, Madsen, et al., 2018; Swanson et al., 2011; Umeno et al., 2020; Wang et al., 2020; Wołyńczyk‐Gmaj et al., 2017). Seventeen articles provided a mean or median gestational age for the sample, which ranged from 14 to 39 weeks (Dorheim et al., 2012; Facco et al., 2010; Felder et al., 2019; Fernández‐Alonso et al., 2012; Kalmbach et al., 2020; Kiviruusu et al., 2020; Ko et al., 2012; Manber et al., 2013; Mourady et al., 2017; Nacar & Tashan, 2019; Okun & O’Brien, 2018; Osnes et al., 2020; Palagini et al., 2019; Sedov, Madsen, et al., 2018; Umeno et al., 2020; Wang et al., 2020; Wołyńczyk‐Gmaj et al., 2017). Eleven articles provided information on prevalence of depression within the sample, which ranged from 9.8% to 68.0% (Dorheim et al., 2012; Kalmbach et al., 2020; Kiviruusu et al., 2020; Kızılırmak et al., 2012; Louis et al., 2018; Manber et al., 2013; Mourady et al., 2017; Nacar & Tashan, 2019; Osnes et al., 2020; Palagini et al., 2019; Swanson et al., 2011).…”

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

Insomnia symptoms during pregnancy: A meta‐analysis

Sedov

Anderson

Dhillon

et al. 2020

Journal of Sleep Research

View full text Add to dashboard Cite

Reports of sleep disturbances are common during pregnancy, yet estimates of prevalence of insomnia symptoms during pregnancy vary widely. The goals of the current review were to summarize the existing data on prevalence of insomnia symptoms during pregnancy and to explore potential moderators, including trimester, gestational age, maternal age, symptoms of anxiety and symptoms of depression. A systematic search of PubMed, PsycInfo and Web of Science was conducted for articles published from inception up to June 2020. In total, 24 studies with a total of 15,564 participants were included in the analysis. The overall prevalence of insomnia symptoms during pregnancy was 38.2%. Trimester was a significant moderator, such that prevalence of insomnia symptoms was higher in the third trimester (39.7%) compared to first (25.3%) and second (27.2%) trimesters. No other variables significantly moderated the prevalence of insomnia symptoms. The results of the current meta‐analysis suggest that the prevalence of insomnia symptoms is higher during pregnancy, particularly in the third trimester. Future research should examine the efficacy and safety of insomnia treatments with this population.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Insomnia symptoms during pregnancy: A meta‐analysis

Sedov

Anderson

Dhillon

et al. 2020

Journal of Sleep Research

View full text Add to dashboard Cite

show abstract

“…In mid-pregnancy, women with high sleep reactivity report elevated symptoms of insomnia, depression, and anxiety, and are more likely to endorse suicidal ideation. (25) Age also seems to play a part in the development of insomnia-related pregnancy depression as seen in one of the review studies. Pregnant women between 16 and 24 years are at very high risk of mental disorders; services need to target resources for pregnant women under 25, including those in their early 20s (26).…”

Section: Postpartum Depressionmentioning

confidence: 92%

Neuroendocrine Aspects of Pregnancy and Postpartum Depression

2019

View full text Add to dashboard Cite

Introduction. Ties between the endocrine system and mental health are undeniably a consistent point of interest in modern day medicine. Furthermore, mental disturbances due to hormonal changes following childbirth have been mentioned in medical literature since Hippocrates. Considering the dramatic endocrine, paracrine and autocrine changes that occur during gestation, labour and postnatal phase, hormonal theories are not to be ignored in the treatment of postpartum disorders. Results. Reproductive hormones are known to modulate behavioural, emotional and cognitive response, therefore rapid changes in estradiol and progesterone plasma concentrations during pregnancy and labour create a vulnerable terrain leading towards postpartum disorders. New research shows that women suffering from postpartum disorders have abnormal neural responses, suggesting a neuroendocrine explanation for postpartum syndromes. Conclusion. To facilitate further research in this area, we present new information on several hormonal interactions and the psychiatric response involved in pregnancy and labour, offering an interdisciplinary outlook on pregnancy and postpartum disorders. There is enough evidence to suggest that estradiol, progesterone, oxytocin, cortisol and thyroid hormones are some of many hormones involved in postpartum syndromes and tackling their perinatal imbalance with pharmacological substituents or antagonists could be useful as an adjuvant form of treatment in future patients.

show abstract

“…In the normal clinical routine, the effect of hypocaloric diet on mood disorders, such as depression, anxiety, and binge eating disorders, was investigated by using the Zung Self-Rating Depression [58] and Anxiety [59]. Scale and Binge eating scale (BES).…”

Section: Methodsmentioning

confidence: 99%

Hericium erinaceus Improves Mood and Sleep Disorders in Patients Affected by Overweight or Obesity: Could Circulating Pro-BDNF and BDNF Be Potential Biomarkers?

Vigna¹,

Morelli²,

Agnelli³

et al. 2019

Evidence-Based Complementary and Alternative Medicine

View full text Add to dashboard Cite

Epidemiological data indicate that subjects affected by obesity have an increased risk of developing mood disorders. The relationship between obesity and mood disorders is bidirectional. We assessed whether a Hericium erinaceus treatment improved depression, anxiety, sleep, and binge eating disorders after 8 weeks of supplementation in subjects affected by overweight or obesity under a low calorie diet regimen. Looking for a possible clinical biomarker, we assessed the serum balance between brain-derived neurotrophic factor (BDNF) and its precursor pro-BDNF before and after H. erinaceus supplementation. Seventy-seven volunteers affected by overweight or obesity were recruited at the offices of the Department of Preventive Medicine, Luigi Devoto Clinic of Work, Obesity Centre, at the IRCCS Foundation Policlinico Hospital of Milan (Italy). Patients were recruited only if they had a mood and/or sleep disorder and/or were binge eating as evaluated through self-assessment questionnaires. We used two different enzyme-linked immunosorbent assays kits to discriminate circulating levels of pro-BDNF and BDNF. Eight weeks of oral H. erinaceus supplementation decreased depression, anxiety, and sleep disorders. H. erinaceus supplementation improved mood disorders of a depressive-anxious nature and the quality of the nocturnal rest. H. erinaceus increased circulating pro-BDNF levels without any significant change in BDNF circulating levels.

show abstract

Stress-related sleep reactivity is associated with insomnia, psychopathology and suicidality in pregnant women: preliminary results

Cited by 55 publications

References 35 publications

Insomnia symptoms during pregnancy: A meta‐analysis

Insomnia symptoms during pregnancy: A meta‐analysis

Neuroendocrine Aspects of Pregnancy and Postpartum Depression

Hericium erinaceus Improves Mood and Sleep Disorders in Patients Affected by Overweight or Obesity: Could Circulating Pro-BDNF and BDNF Be Potential Biomarkers?

Contact Info

Product

Resources

About